Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
101.68
+4.59 (4.73%)
At close: Mar 19, 2026, 4:00 PM EDT
101.99
+0.31 (0.30%)
Pre-market: Mar 20, 2026, 8:08 AM EDT

Protagonist Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,4885,4662,3561,3235381,636
Market Cap Growth
173.40%131.99%78.04%145.83%-67.10%85.52%
Enterprise Value
5,8524,9061,947981.64302.081,313
Last Close Price
101.6887.3438.6022.9310.9134.20
PE Ratio
--42.609.13-16.50-4.20-12.62
Forward PE
33.9359.76----
PS Ratio
141.00118.785.4222.0520.2559.80
PB Ratio
10.358.893.493.932.505.45
P/TBV Ratio
10.529.033.723.872.485.28
P/FCF Ratio
115.6997.4612.89-18.68-4.94-15.01
P/OCF Ratio
112.5094.7712.79-18.84-4.98-15.17
EV/Sales Ratio
127.18106.624.4816.3611.3647.99
EV/EBITDA Ratio
--31.287.68-10.59-2.32-10.50
EV/EBIT Ratio
--31.037.70-10.48-2.30-10.43
EV/FCF Ratio
104.3687.4810.65-13.86-2.77-12.05
Debt / Equity Ratio
0.010.010.0200.010.01
Debt / EBITDA Ratio
-0.07-0.070.04-0.01-0.03-0.05
Debt / FCF Ratio
0.180.180.06-0.02-0.03-0.05
Net Debt / Equity Ratio
-0.91-0.91-0.60-1.01-1.08-1.07
Net Debt / EBITDA Ratio
3.553.55-1.613.671.792.57
Net Debt / FCF Ratio
-9.93-9.93-2.234.812.152.95
Asset Turnover
0.070.070.790.200.090.08
Quick Ratio
12.4912.4912.3216.537.617.53
Current Ratio
12.7112.7112.4816.717.807.74
Return on Equity (ROE)
-33.47%-20.18%54.39%-28.59%-49.41%-43.32%
Return on Assets (ROA)
-22.53%-22.53%45.17%-30.91%-44.11%-37.44%
Return on Invested Capital (ROIC)
-86.56%-86.56%167.86%855.66%700.45%1004.11%
Return on Capital Employed (ROCE)
-23.96%-23.96%48.91%-33.84%-50.49%-42.81%
Earnings Yield
-2.01%-2.35%10.96%-6.06%-23.83%-7.92%
FCF Yield
0.86%1.03%7.76%-5.35%-20.24%-6.66%
Buyback Yield / Dilution
-0.42%-0.42%-1.10%-12.88%-3.49%-7.94%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q